Livio B.
- Country
- Italy
- Department
- U.O. Oncologia Medica
Research Overview
- Sotorasib and Combination Therapy Versus Standard Chemotherapy in Treatment-Naïve Patients with KRAS p.G12C-Mutated Metastatic Colorectal Cancer
- Phase 3 Randomized Study of Intermittent vs. Continuous Panitumumab Plus FOLFIRI in Unresectable Left-Sided RAS/B-RAF Wild-Type Metastatic Colorectal Cancer
- Phase III Randomized Trial of Short vs. Long-Course Preoperative Chemotherapy with mFOLFIRINOX or PAXG in Stage I-III Pancreatic Ductal Adenocarcinoma
Data & Insights
Has run more than one trial at 46 of 222 partner sites.
Specializations
Colorectal Cancer Research
This investigator specializes in advanced therapeutic approaches for metastatic colorectal cancer, with particular focus on RAS/BRAF wild type variants. Their research encompasses innovative combination therapies and targeted treatment strategies.
- Treatment-resistant colorectal cancer
- Targeted molecular therapies
- Left-sided colorectal tumors
The investigator explores various treatment modalities including immunotherapy combinations and antibody-based interventions.
Pancreatic Cancer Studies
The investigator conducts research in pancreatic ductal adenocarcinoma, focusing on optimizing pre-operative chemotherapy protocols and treatment duration strategies.
- Early-stage pancreatic cancer
- Chemotherapy optimization
- Treatment duration assessment
Their work includes comparative analyses of different chemotherapy regimens for pancreatic cancer treatment.
Treatment Innovation
The investigator develops innovative treatment protocols exploring intermittent versus continuous therapy approaches in gastrointestinal cancers.
- Biomarker research
- Treatment resistance mechanisms
- Quality of life assessment
Their research includes extensive monitoring of treatment efficacy through tissue and blood sample analysis.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.